• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

根据 2004 年世卫组织的分类方案，你对良性、癌前病变、非浸润性和浸润性膀胱癌病变了解多少？

How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?

机构信息

Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region (Ancona), Ancona, Italy.

出版信息

Diagn Pathol. 2011 Apr 7;6:31. doi: 10.1186/1746-1596-6-31.

DOI:10.1186/1746-1596-6-31
PMID:21473752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3107770/
Abstract

The aim of this essay is the self assessment of the level of knowledge of the 2004 WHO classification of bladder neoplasms through a series of MCQs, each associated a short commentary. This paper is directed to all who are involved with the application of this classification at the anticancer research, diagnostic, prognostic and therapeutic levels, in particular to uropathologists, urologists and oncologists.

摘要

本文旨在通过一系列与短文注释相关的多项选择题，对自身 2004 年世卫组织膀胱肿瘤分类知识水平进行评估。本文面向所有参与该分类在抗癌研究、诊断、预后和治疗水平应用的人员，特别是尿病理学家、泌尿科医生和肿瘤学家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/10fe5330c196/1746-1596-6-31-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/d4f9682a1661/1746-1596-6-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/117f680e2fc8/1746-1596-6-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/591ebd5f9241/1746-1596-6-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/a958af49c086/1746-1596-6-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/8709321b9c7c/1746-1596-6-31-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/2c8ec2d9310a/1746-1596-6-31-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/acaeb6f064c4/1746-1596-6-31-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/15c28b1cebbf/1746-1596-6-31-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/b6ffaa5dff9f/1746-1596-6-31-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/fe31a1defc4b/1746-1596-6-31-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/5af054918894/1746-1596-6-31-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/ef501a3a085a/1746-1596-6-31-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/10fe5330c196/1746-1596-6-31-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/d4f9682a1661/1746-1596-6-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/117f680e2fc8/1746-1596-6-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/591ebd5f9241/1746-1596-6-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/a958af49c086/1746-1596-6-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/8709321b9c7c/1746-1596-6-31-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/2c8ec2d9310a/1746-1596-6-31-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/acaeb6f064c4/1746-1596-6-31-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/15c28b1cebbf/1746-1596-6-31-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/b6ffaa5dff9f/1746-1596-6-31-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/fe31a1defc4b/1746-1596-6-31-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/5af054918894/1746-1596-6-31-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/ef501a3a085a/1746-1596-6-31-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef2/3107770/10fe5330c196/1746-1596-6-31-13.jpg

相似文献

1
How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?根据 2004 年世卫组织的分类方案，你对良性、癌前病变、非浸润性和浸润性膀胱癌病变了解多少？
Diagn Pathol. 2011 Apr 7;6:31. doi: 10.1186/1746-1596-6-31.
2
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder.膀胱良性、癌前及非侵袭性肿瘤性病变的形态学分类及定义
Histopathology. 2008 Dec;53(6):621-33. doi: 10.1111/j.1365-2559.2008.03025.x. Epub 2008 Apr 18.
3
[Recent advances in diagnosis of flat lesions of urinary bladder].[膀胱扁平病变诊断的最新进展]
Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):577-81.
4
[Hyperplastic-proliferative and preneoplastic lesions of the bladder urothelium (author's transl)].膀胱尿路上皮的增生性-增殖性和癌前病变（作者译）
Pathologica. 1981 Jul-Aug;73(1026):597-612.
5
Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.膀胱的癌前非乳头状病变及情况：基于安科纳国际咨询会议的最新进展
Virchows Arch. 2002 Jan;440(1):3-11. doi: 10.1007/s00428-001-0577-6.
6
Detection of neoplastic and preneoplastic urothelia by combined scanning and transmission electron microscopy of urinary surface of human and rat bladders.通过对人和大鼠膀胱尿表面进行联合扫描和透射电子显微镜检查来检测肿瘤性和肿瘤前尿路上皮。
Histopathology. 1977 Mar;1(2):125-35. doi: 10.1111/j.1365-2559.1977.tb01651.x.
7
[So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].[所谓的“浅表性”膀胱肿瘤。2003年的哪种分类？第2部分：扁平尿路上皮病变]
Ann Pathol. 2003 Feb;23(1):35-45.
8
Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice.膀胱扁平上皮内病变——增生、发育不良和意义不明的非典型性是否需要作为诊断实体存在？以及在常规临床实践中如何处理。
Mod Pathol. 2022 Oct;35(10):1296-1305. doi: 10.1038/s41379-022-01087-7. Epub 2022 Apr 25.
9
Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.尿路上皮异型增生和其他扁平状膀胱病变：临床病理和分子特征。
Hum Pathol. 2010 Feb;41(2):155-62. doi: 10.1016/j.humpath.2009.07.002. Epub 2009 Sep 16.
10
Review. Non-papillary urothelial lesions of the urinary bladder: morphological classification and immunohistochemical markers.综述：膀胱非乳头状尿路上皮病变：形态学分类及免疫组化标志物
In Vivo. 2008 Jul-Aug;22(4):493-501.

引用本文的文献

1
The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.死亡结构域相关蛋白（DAXX）表达的临床意义
Korean J Thorac Cardiovasc Surg. 2018 Jun;51(3):187-194. doi: 10.5090/kjtcs.2018.51.3.187. Epub 2018 Jun 5.
2
Cigarette smoke extract-induced proliferation of normal human urothelial cells via the MAPK/AP-1 pathway.香烟烟雾提取物通过MAPK/AP-1途径诱导正常人膀胱上皮细胞增殖。
Oncol Lett. 2017 Jan;13(1):469-475. doi: 10.3892/ol.2016.5407. Epub 2016 Nov 22.
3
Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.

本文引用的文献

1
Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management.具有倒置生长模式的尿路上皮病变：组织发生、分子遗传学发现、鉴别诊断和临床管理。
BJU Int. 2011 Feb;107(4):532-7. doi: 10.1111/j.1464-410X.2010.09853.x. Epub 2010 Nov 23.
2
Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.尿路上皮异型增生和其他扁平状膀胱病变：临床病理和分子特征。
Hum Pathol. 2010 Feb;41(2):155-62. doi: 10.1016/j.humpath.2009.07.002. Epub 2009 Sep 16.
3
Staging and reporting of urothelial carcinoma of the urinary bladder.
高级别尿路上皮癌中染色质重塑因子 DAXX 的免疫组化分析。
Diagn Pathol. 2013 Jul 2;8:111. doi: 10.1186/1746-1596-8-111.
膀胱尿路上皮癌的分期与报告
Mod Pathol. 2009 Jun;22 Suppl 2:S70-95. doi: 10.1038/modpathol.2009.1.
4
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder.膀胱良性、癌前及非侵袭性肿瘤性病变的形态学分类及定义
Histopathology. 2008 Dec;53(6):621-33. doi: 10.1111/j.1365-2559.2008.03025.x. Epub 2008 Apr 18.
5
Morphological diagnosis of urothelial neoplasms.尿路上皮肿瘤的形态学诊断
J Clin Pathol. 2008 Jan;61(1):3-10. doi: 10.1136/jcp.2007.049312. Epub 2007 Jun 1.
6
Histologic grading of noninvasive papillary urothelial neoplasms.非浸润性乳头状尿路上皮肿瘤的组织学分级
Eur Urol. 2007 Apr;51(4):889-97; discussion 897-8. doi: 10.1016/j.eururo.2006.10.037. Epub 2006 Oct 27.
7
Inverted papilloma of the urinary bladder: a molecular genetic appraisal.膀胱内翻性乳头状瘤：分子遗传学评估
Mod Pathol. 2006 Oct;19(10):1289-94. doi: 10.1038/modpathol.3800667. Epub 2006 Jul 21.
8
The 2004 WHO classification of bladder tumors: a summary and commentary.2004年世界卫生组织膀胱肿瘤分类：总结与评论
Int J Surg Pathol. 2005 Apr;13(2):143-53. doi: 10.1177/106689690501300203.
9
Is surveillance necessary for inverted papilloma in the urinary bladder and urethra?膀胱和尿道内翻性乳头状瘤是否需要进行监测？
ANZ J Surg. 2005 Apr;75(4):213-7. doi: 10.1111/j.1445-2197.2005.03327.x.
10
Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.世界卫生组织/国际泌尿病理学会（WHO/ISUP）与世界卫生组织（WHO）对非浸润性乳头状尿路上皮肿瘤进展风险分类的比较。
Urology. 2002 Aug;60(2):315-9. doi: 10.1016/s0090-4295(02)01705-3.